Health Condition 1: Z00-Z13- Persons encountering health services for examinations
Conditions
Interventions
Intervention1: Prednisolone: Evaluation of anti-oxidative and anti-inflammatory biomarkers level on Prednisolone tablet oral treatment of one month duration daily OD or BD (depending on disease severi
Sponsors
DEPARTMENT OF HEALTH RESEARCH
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients of 18-60 yrs age group 2. Patients willing to provide written informed consent 3. Patients diagnosed with IBD
Exclusion criteria
Exclusion criteria: 1. Patients with smoking, or alcohol addiction during the last 3 months 2. Patients who are not willing to provide written informed consent 3. Pregnant and lactating women 4. Patients with history of allergy to the study drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This is the first study which will emphasis over the biomarkers status at antioxidative and anti-inflammatory level which is required in the present time to develop a long term effective therapy for IBD patientsTimepoint: at baseline and after one month of treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| a long term effective therapy along with no or little side effects for the better lifestyle of IBD patientsTimepoint: 1 At baseline 2 after one month of treatment | — |
Countries
India
Contacts
Public ContactDr Savita Devi
KALPANA CHAWLA GOVT. MEDICAL COLLEGE KARNAL
Outcome results
None listed